ReviewComputational and structural biotechnology journal2025
A Nano Risk Governance Portal supporting risk governance of nanomaterials and nano-enabled products.
Review in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanotoxicity of Porous Silica Nanoparticles: Physicochemical Properties and Mechanistic Cellular Endpoints.Nanomaterials (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Risk governance (RG) of nanomaterials (NMs) has been at the focus of the Horizon 2020 Programme of the European Union, through the funding of three research projects (Gov4Nano, NANORIGO, RISKGONE). The extensive collaboration of the three projects, in various scientific topics, aimed to enhance RG of NMs and provide a solid scientific basis for effective collaboration of the various types of stakeholders involved. In this paper the development of a digital Nano Risk Governance Portal (NRGP) and associated information technology (IT) infrastructure supporting the risk governance of (engineered) nanomaterials and nano-enabled products, is presented, alongside considerations for future work and enhancement within the domain of Advanced Materials (AdMa). This paper describes several elements of this digital portal, which serves as a single-entry point for all stakeholders in need of, or interested in, nano-risk governance aspects. In its simplest form, the NRGP allows users to be efficiently guided towards tailored information about nanomaterials, risk governance concepts, guidance documents, harmonized methods for risk assessment, publicly accessible data, information and knowledge, as well as a directory of tools, to assess the exposure and hazard of nanomaterials and perform Safe-and-Sustainable-by-Design (SSbD) assessment in the context of nano-risk governance. This paper presents the technical implementation and the content of the first version of the NRGP alongside the vision for the future and further plans for development, implementation, hosting and maintenance of the NRGP aimed at ensuring its sustainability. This includes a procedure to link to, or include, currently available and future (nano)material-related (cloud) platforms, decision support systems, tools, guidance, and databases in line with good governance objectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.